Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
11/2008
11/25/2008US7456171 Nicotinic ligands; treatment of nervous system disorders, neurodegenerative disorders, psychological disorders, and tobacco, drug and alcohol withdrawal symptoms
11/20/2008WO2008141079A1 Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
11/20/2008WO2008138232A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008US20080287478 Nociceptin Analogues and Uses Thereof
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/20/2008CA2685757A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008CA2685520A1 Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
11/19/2008EP1992628A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
11/19/2008CN101307052A Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/13/2008WO2008136756A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008US20080280928 Pyrrolopyrimidine and Pyrrolopyridine Derivatives Substituted with a Cyclic Amino Group As Crf Antagonists
11/13/2008CA2686707A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1989212A2 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
11/12/2008EP1315490B1 A method for treating allergies using substituted pyrazoles
11/12/2008EP1261607B1 2,4-disubstituted thiazolyl derivatives
11/12/2008CN101302227A Method for synthesizing 3,3í»-purrocoline compounds
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449476 e.g. 2,3,4,5-tetrahydro-2-[2-[4-methoxy-7-(5-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-5-phenyl-1H-pyrido[4,3-b]indole; inhibit HIV entry by attaching to exterior viral envelop protein gp120 and interrupting viral entry process by interfering with cellular receptor CD4
11/06/2008US20080275235 Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors
11/05/2008EP1988093A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
11/05/2008EP1987042A2 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
11/05/2008EP1987034A1 Spiro condensed piperidnes as modulators of muscarinic receptors
11/05/2008EP1608663B1 Pyrrolo (2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof
11/05/2008EP1319000B1 Use of 1-azabicyclo 2.2.2 octan-3-one derivatives for treating cancer tumors
11/05/2008EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents
11/05/2008CN101298456A Cephalosporin derivate containing pyrrolidinezolo piperazinium
11/05/2008CN101298455A Cephalosporin derivate containing triazolo pyridazinium
11/05/2008CN101298454A Cephalosporin derivate containing pyrazolo triazinium
11/05/2008CN101298453A Cephalosporin derivatives containing trizolopyrimidine
11/05/2008CN100430398C Diazabicyclic central nervous systems active agents
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/05/2008CN100430393C Pyran derivative
11/04/2008US7446212 Polymethine ethers
10/2008
10/30/2008WO2008128961A1 Compounds
10/30/2008WO2008128953A1 Tricyclic nitrogen containing heterocycles as antibacterial agents
10/30/2008WO2008128942A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008CA2684659A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/29/2008EP1984366A1 3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
10/29/2008EP1531811B1 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
10/29/2008CN101293892A Biapenem dimer and preparation method thereof
10/29/2008CN100429215C Method for improving vinblastine content in madagascar periwinkle
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126034A2 Oxazolidinone antibiotics
10/23/2008WO2008125945A2 3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c
10/23/2008WO2007080325A8 Fgf-receptor agonist dimeric compounds
10/23/2008US20080261963 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008CA2683695A1 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
10/23/2008CA2679071A1 Oxazolidinone antibiotics
10/22/2008EP1982988A1 Method for synthesis of ciguatoxin ctx1b and compound useful for the synthesis of ciguatoxin ctx1b
10/22/2008EP1549652B1 Fused azole-pyrimidine derivatives
10/22/2008CN100427486C Novel benzimidazole derivatives
10/21/2008US7439364 Process for the synthesis of derivatives of halo-[2,3-F] quinoline
10/21/2008US7439236 Pharmaceutical composition for the treatment of CNS and other disorders
10/21/2008CA2438294C Pyridopyrimidine or naphthyridine derivative
10/16/2008WO2008124153A1 Heteroaryl amide analogues as p2x7 antagonists
10/16/2008WO2008124026A1 Wortmannin-rapamycin conjugate and uses thereof
10/16/2008WO2008124020A1 Wortmannin-rapalog conjugate and uses thereof
10/16/2008WO2008122615A1 [2, 6] naphthyridines useful as protein kinase inhibitors
10/16/2008WO2008014240A3 Dimeric iap inhibitors
10/16/2008CA2682925A1 Heteroaryl amide analogues
10/16/2008CA2682340A1 [2 , 6] naphthyridines useful as protein kinase inhibitors
10/16/2008CA2680683A1 Wortmannin-rapalog conjugate and uses thereof
10/16/2008CA2678415A1 Wortmannin-rapamycin conjugate and uses thereof
10/15/2008EP1979351A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
10/15/2008EP1802637B1 Cgrp receptor antagonists
10/15/2008EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors
10/15/2008EP1567520B1 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008CN101287733A Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities
10/15/2008CN101284842A Method for preparing vinorelbine tartrate with vinblastine sulfate
10/15/2008CN101284841A Separation and purification method of vinorelbine
10/09/2008WO2008119950A1 Porphyrin compounds
10/08/2008EP1976853A1 Novel compounds and use thereof
10/08/2008EP1641799B8 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432267 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
10/02/2008WO2008116665A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
10/02/2008WO2008084223A3 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/02/2008US20080242668 Neurodegenerative, inflammatory disorders, pain, drug abuse; useful as diagnostic tools or monitoring agents such as for neuroimaging, labelling; nicotinic and/or monoamine receptors modulators; 2,2'-Bis-((+-)-1-aza-bicyclo[2.2.2]oct-3-yloxy)-[5,5']-bithiazolyl; cholinergic ligands
10/01/2008EP1974732A1 Therapeutic agent for neurodegenerative disease
10/01/2008EP1974729A1 Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
10/01/2008EP1973914A2 Transforming growth factor modulators
10/01/2008EP1973909A2 Transforming growth factor modulators
10/01/2008CN100422182C Imidazopyridine-derivatives as inducible NO-synthase inhibitors
10/01/2008CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists
09/2008
09/30/2008US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation
09/25/2008WO2008094574A3 Furanone compounds and methods of making and using the same
09/25/2008WO2008060597A3 Compounds useful as protein kinase inhibitors
09/25/2008US20080234296 Triazolo[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists
09/24/2008EP1971613A1 Crystalline form of vinflunine ditartrate
09/24/2008CN101272785A Tetrahydro- beta-carbolin-sulfonamide derivatives as 5-HT6 ligands
09/23/2008US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
09/23/2008US7427445 Compound capable of being used in organic layer of organic light emitting device
09/23/2008CA2480800C Inhibitors of akt activity
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 111